Melanoma-associated Peptides in Research

Melanoma-associated peptides are pivotal in cancer immunotherapy, particularly in targeting tumor-specific antigens and enhancing T cell responses. JPT’s peptides are widely used in melanoma research to improve tumor targeting and immunotherapy efficacy. Below, you will find key studies referencing JPT’s melanoma-associated peptides in various researches.

References with Melanoma-associated peptides

2021-2022

2021-2022

Archive

Archive

  • Neoantigens in Cancer Immunotherapy - Review
    Schumacher & Schreiber, Science (2015) - PMID: 25838375
  • An Immunogenic Personal Neoantigen Vaccine for Patients with Melanoma - Letter 
    Ott et al., Nature (2017) - PMID: 28678778
Loading...

Check our list of products, click and go.

Get a quote